Prevalence of Metabolic Dysfunction-associated Steatotic Liver Disease and Cardiometabolic Risk Factor in US Adolescents - Takeaways - MDSpire

Prevalence of Metabolic Dysfunction-associated Steatotic Liver Disease and Cardiometabolic Risk Factor in US Adolescents

  • By

  • Xiaoyan Zheng

  • Dongying Zhao

  • Liwei Wang

  • Yiwen Wang

  • Yan Chen

  • Yongjun Zhang

  • August 13, 2024

  • 0 min

Share

  • 1

    The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) in US adolescents is 23.77%.

  • 2

    Isolated overweight/obesity is the most common cardiometabolic risk factor (CMRF) at 35% among adolescents with MASLD.

  • 3

    Non-Hispanic Black adolescents exhibit the highest rates of overweight/obesity combined with elevated glucose.

  • 4

    Increased controlled attenuation parameter (CAP) values are significantly associated with overweight/obesity and other CMRFs.

  • 5

    The study highlights the alarming prevalence of MASLD and the critical role of overweight/obesity in adolescent health.

Original Source(s)

Prevalence of Metabolic Dysfunction-associated Steatotic Liver Disease and Cardiometabolic Risk Factor in US Adolescents

  • by Xiaoyan Zheng, Dongying Zhao, Liwei Wang, Yiwen Wang, Yan Chen, Yongjun Zhang

  • August 13, 2024

Related Content

Editorial: Cardiovascular Anthropometry For Large Scale Population Studies Volume II

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.

Pheochromocytoma complicated with acute myocardial infarction and cerebral infarction: a case report